{"id":"W4406199775","doi":"10.1159/000543320","title":"Patient Preferences for HR+/HER2− Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice Experiment","year":2025,"lang":"en","type":"article","venue":"Breast Care","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Canadian Breast Cancer Network; Jewish General Hospital","funders":"Arthritis Society; Canadian Institutes of Health Research; Genome Canada; Alberta Innovates; Seagen; Gilead Sciences; Amgen; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Adjuvant; Breast cancer; Oncology; Cancer; Internal medicine; Gynecology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01495277,0.0007770156,0.0008218384,0.0002141888,0.00050669,0.001401988,0.0007137912,0.001395577,0.005825019],"category_scores_gemma":[0.01964735,0.0004452997,0.001191807,0.0002251777,0.001046585,0.001036954,0.0007562761,0.001688399,0.0004098837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009085867,"about_ca_system_score_gemma":0.0009747986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004798268,"about_ca_topic_score_gemma":0.000474228,"domain_scores_codex":[0.9933722,0.005337348,0.0002455297,0.0004046917,0.0003603532,0.0002799756],"domain_scores_gemma":[0.970252,0.02427273,0.003193351,0.001080104,0.0002589323,0.0009428065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3873518,0.1844595,0.135778,0.002287725,0.003551098,0.0008591855,0.01145539,0.100569,0.03606232,0.0168642,0.002757763,0.118004],"study_design_scores_gemma":[0.05925688,0.3952364,0.1004601,0.0002873496,0.001612124,0.0005746863,0.003483637,0.3951598,0.0141552,0.02405562,0.005253773,0.0004645057],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997659,0.00001965087,0.001249474,0.00008718032,0.00001153834,0.0004699694,0.00007784237,0.00000528645,0.0004201384],"genre_scores_gemma":[0.9929143,0.00003173296,0.004553514,0.0001534736,0.00001685545,0.001717315,0.00008110253,0.000002066135,0.0005296716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01495277,"threshold_uncertainty_score":0.07907879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008287516024385187,"score_gpt":0.2836518464489157,"score_spread":0.2753643304245305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}